Here, our study indicates that URGCP promotes glioma growth through upregulating Cyclin D1 and Cyclin E1 expression, and the NF-κB/c-myc/miR-16 pathway is involved in URGCP-mediated Cyclin D1 and Cyclin E1 overexpression in glioma. This evidence concerns the gene MYC and glioma.